4//SEC Filing
BREITMEYER JAMES B 4
Accession 0001209191-24-003413
CIK 0001260990other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 6:00 PM ET
Size
7.8 KB
Accession
0001209191-24-003413
Insider Transaction Report
Form 4
BREITMEYER JAMES B
DirectorPresident, CEO
Transactions
- Award
Stock Option
2024-02-14+28,400→ 28,400 totalExercise: $9.18Exp: 2034-02-14→ Common Stock (28,400 underlying) - Award
Stock Option
2024-02-14+6,200→ 6,200 total(indirect: By Spouse)Exercise: $9.18Exp: 2034-02-14→ Common Stock (6,200 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest on first anniversary of the date of grant, and the remaining shares subject to the option vest in 36 equal monthly installments, subject to the recipient's continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001244823
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 6:00 PM ET
- Size
- 7.8 KB